Stay updated on Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRepresents a software version update for the page, from v3.6.4 to v3.6.5. This deployment likely includes fixes or minor improvements and does not change the study content shown on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows Revision: v3.6.4 replacing Revision: v3.6.3. This appears to be a minor backend update to the study page with no changes to visible content or data.SummaryDifference0.1%

- Check47 days agoChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, signaling a newer version of the study protocol/document referenced on the page.SummaryDifference0.1%

- Check54 days agoChange DetectedThe document revision was updated from v3.6.0 to v3.6.2, signaling a newer version of the trial-related documentation linked on the page. This reflects an update to the document's version rather than changes to the page's core content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study page now indicates that recruitment has ended, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to guide users in understanding and interacting with the study record.SummaryDifference0.4%

- Check76 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page's documentation. No study content, data, or functionality were changed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.